FY2027 Earnings Forecast for MDA Space Issued By Scotiabank

MDA Space Ltd. (TSE:MDA) – Investment analysts at Scotiabank boosted their FY2027 earnings per share estimates for shares of MDA Space in a note issued to investors on Friday, June 26th. Scotiabank analyst K. Gupta now forecasts that the company will earn $1.58 per share for the year, up from their previous forecast of $1.57. Scotiabank has a “Sector Outperform” rating and a $71.00 price objective on the stock. The consensus estimate for MDA Space’s current full-year earnings is $0.96 per share.

MDA Space (TSE:MDA) last released its earnings results on Thursday, May 7th. The company reported C$0.38 earnings per share for the quarter. MDA Space had a return on equity of 7.24% and a net margin of 6.02%.The business had revenue of C$464.10 million for the quarter.

Other research analysts also recently issued research reports about the stock. Jefferies Financial Group raised shares of MDA Space to a “strong-buy” rating in a research note on Wednesday, June 10th. Scotia boosted their price objective on shares of MDA Space from C$53.00 to C$70.00 and gave the company a “sector outperform” rating in a research report on Thursday, May 28th. Stifel Nicolaus upped their target price on shares of MDA Space from C$70.00 to C$75.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. Canaccord Genuity Group raised their target price on shares of MDA Space from C$56.00 to C$65.00 and gave the stock a “buy” rating in a research report on Monday, June 22nd. Finally, Desjardins lifted their price target on shares of MDA Space from C$66.00 to C$70.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of C$63.40.

MDA Space Stock Up 8.5%

Shares of MDA opened at C$58.60 on Wednesday. The firm has a fifty day moving average price of C$52.64 and a 200-day moving average price of C$41.95. The company has a current ratio of 0.80, a quick ratio of 1.00 and a debt-to-equity ratio of 20.62. The firm has a market capitalization of C$8.13 billion, a P/E ratio of 73.85 and a beta of -0.53. MDA Space has a 12-month low of C$20.85 and a 12-month high of C$67.90.

Insider Buying and Selling

In other news, insider Holly Lynn Johnson sold 45,000 shares of MDA Space stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of C$52.79, for a total value of C$2,375,550.00. Following the transaction, the insider directly owned 60,331 shares in the company, valued at approximately C$3,184,873.49. This trade represents a 42.72% decrease in their position. Also, insider Guillaume Lavoie sold 1,500 shares of the business’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of C$52.63, for a total value of C$78,945.00. Following the completion of the transaction, the insider directly owned 6,257 shares of the company’s stock, valued at approximately C$329,305.91. The trade was a 19.34% decrease in their ownership of the stock. Over the last 90 days, insiders have sold 119,269 shares of company stock valued at $6,318,903. 12.60% of the stock is owned by insiders.

MDA Space Company Profile

Building the space between proven and possible, MDA Space (TSX:MDA; NYSE:MDA) is a trusted mission partner to the global defence and space industry. A robotics, satellite systems and geointelligence pioneer with a 55-year+ story of world firsts and more than 450 missions, MDA Space is a global leader in communications satellites, Earth and space observation, and space exploration and infrastructure. The global MDA Space team of more than 4,000 space experts has the knowledge and know-how to turn an audacious customer vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that’s been in our DNA since day one.